Peanut Allergy
📧 Sign up to get email alerts when something new happens for Peanut Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Predicting Peanut Anaphylaxis and Reducing Epinephrine [NA]
This clinical trial update reports completion and posted results on predicting peanut-related anaphylaxis and reducing epinephrine use. The …
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg [NA]
A University of Rochester clinical trial is currently recruiting to study whether consumption or avoidance of peanut and egg by pregnant wom…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Using Commonly Available Food Products To Treat Food Allergy [NA]
A clinical trial is recruiting to evaluate whether commonly available food products can treat food allergies. The study targets IgE-mediated…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children [Phase 3]
This clinical trial update reports the completion of a Phase 3 follow-up study (EPITOPE) assessing long-term efficacy and safety of DBV712 i…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT [NA]
Clinical trial status update for Karolinska Institutet's peanut oral immunotherapy study in young children. The trial is currently active bu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) [Phase 2]
Phase 2 clinical trial (COMBINE) evaluating biologics to improve outcomes of oral immunotherapy for food and peanut allergies has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts [Phase 2]
A Phase 2 study evaluating the efficacy, safety and tolerability of remibrutinib in adults with peanut allergy has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: The Effect of Per Oral Immunotherapy in Severe Milk, Peanut and Egg Allergy in Adults [NA]
Completed clinical trial evaluating per oral immunotherapy for adults with severe milk, peanut, and egg allergy. Results posted in May 2025.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Immune-supportive Diet and Gut Permeability in Allergic Children [NA]
Clinical trial update: a study evaluating an immune-supportive diet and gut permeability in children with peanut or nut allergies is current…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Oral Immunotherapy for Peanut Allergic Patients [Phase 1, Phase 2]
Phase 1/Phase 2 oral immunotherapy trial for peanut allergy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Predictors of Persistent Peanut Allergy at Age 5 Years
This entry reports a clinical trial studying predictors of persistent peanut allergy by age 5, currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Evaluation of a Supervised Clinical Feeding Intervention [NA]
Clinical trial update for a supervised feeding intervention in children with peanut allergy; recruitment has not started.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: EPAP, Interviewstudy
Clinical trial update for EPAP interview study sponsored by Charité University, Berlin, currently recruiting for food allergy and peanut all…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy [Phase 2]
Phase 2 clinical trial update investigating the immune basis and clinical implications of threshold-based phenotypes in peanut allergy; resu…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Peanut and Tree Nut Desensitization [NA]
Clinical trial from McGill University Health Centre investigating desensitization therapies for peanut allergy and tree nut allergy. The stu…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) [Phase 3]
This update reports longer-term results for AR101 in participants who previously enrolled in ARC008, providing insights from a Phase 3 peanu…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age [Phase 3]
Phase 3 safety and efficacy study evaluating Viaskin Peanut in peanut-allergic children aged 1-3 years; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy [Phase 2]
A Phase 2 study evaluated abatacept as an adjuvant to peanut oral immunotherapy to promote remission in peanut allergy, and the trial has co…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine [Phase 1]
A completed Phase 1 study evaluated the safety, tolerability, and immune response of ASP0892 (ARA-LAMP-vax), a multivalent peanut DNA vaccin…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine [Phase 1]
A Phase 1 study evaluated safety, tolerability and immune response to ASP0892 (ARA-LAMP-vax), a multivalent DNA plasmid vaccine targeting pe…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy [Phase 3]
A Phase 3 trial evaluating ligelizumab (QGE031) for peanut allergy was terminated, with efficacy and safety results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Boiled Peanut Oral Immunotherapy [Phase 1]
Results from a Phase 1 trial of Boiled Peanut Oral Immunotherapy for peanut allergy have been posted, indicating the study has completed enr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Intervention to Reduce Early (Peanut) Allergy in Children [NA]
A completed clinical trial evaluating an intervention to prevent early peanut allergy in children with results posted in September 2024.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy [Phase 2]
A Phase 2 trial comparing high-dose PPOIT and high-dose peanut OIT to low-dose peanut OIT for peanut allergy has been withdrawn; no results …
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy
This clinical trial update examines the role of filaggrin gene mutations in sensitization pathways contributing to allergic rhinitis and pea…